Table 2.
Validation studies of preoperative models
Ref.
|
Period + number
|
Sample region
|
Operation
|
Characteristics
|
Source of data
|
Models tested
|
Outcomes tested
|
Zingg et al[42], 2009 | 1990-2007 (346) | Switzerland/Australia | TT | N: 140/346; H: 259 AC/71 SCC | Two centres | Rotterdam score; Philadelphia score | Mortality |
Grotenhuis et al[43], 2010 | 1991-2008 (777) | Netherlands | TT/TH | N: 221/777; H: N/A | Single centre | Amsterdam score | Morbidity |
Bosch et al[44], 2011 | 1991-2007 (278) | Netherlands | TT | N: 10/278; H: 235 AC/43 SCC | Single centre | ACCI; CCI; O-POSSUM; P-POSSUM | Mortality |
Ferguson et al[45], 2011 | 1980-2009 (514) | United States | TT/TH/hybrid/MIE | N: 167/514; H: 261 AC/137 SCC | Single centre | Amsterdam score | Morbidity + major morbidity |
Filip et al[46], 2014 | 2004-2013 (43) | Romania | TT/TH | N: 22/43; H: 33 SCC/9 AC | Single centre | ACCI; CCI; POSSUM; O-POSSUM; P-POSSUM | Mortality |
Yamana et al[47], 2015 | 2005-2013 (251) | Japan | TT/MIE | N: 150/251; H: N/A | Single centre | GNRI; PNI; E-PASS; POSSUM | Respiratory complications |
Lindner et al[48], 2016 | 2005-2009 (94) | Germany | TT | N: 54/94; H: 94 AC/0 SCC | Single centre | Cologne score | Morbidity |
Reinersman et al[49], 2016 | 2009-2012 (136) | United States | TT/TH/hybrid/MIE | N: 110/136; H: 118 AC/18 SCC | Single centre | Ferguson score | Respiratory complications |
Xing et al[50], 2016 | 2008-2010 (217) | China | TT/TH | N: 0/217; H: 162 SCC/50 AC | Single centre | Ferguson score | Respiratory complications |
Takeuchi et al[51], 2018 | 2000-2016 (438) | Japan | TT | N: 208/438; H: 398 SCC/27 AC | Single centre | Takeuchi model | Mortality |
D’Journo et al[52], 2017 | 2004-2013 (1039) | France | TT/TH | N: 420/1039; H: N/A | National database | Rotterdam score | Mortality |
Gray et al[53], 2020 | 2016-2018 (240) | United States | TT/TH/MIE | N: N/A; H: N/A | Single centre | NSQIP SRC | Morbidity |
Peng et al[54], 2020 | 2012-2019 (218) | United States | MIE | N: 189/218; H: N/A | Single centre | NSQIP SRC | Morbidity + mortality |
Ravindran et al[55], 2020 | 2013-2017 (100) | United States | TT | N: 87/100; H: 75 AC/21 SCC | Single centre | NSQIP SRC | Morbidity + mortality |
TT: Transthoracic; TH: Transhiatal; MIE: Minimally invasive esophagectomy; N: Neoadjuvant chemotherapy; H: Histopathology subtype; SCC: Squamous cell carcinoma; AC: Adenocarcinoma; N/A: Not available; NSQIP SRC: National Surgical Quality Improvement Program Surgical Risk Calculator; ACCI: Age-adjusted charlson comorbidity index; CCI: Charlson comorbidty index; POSSUM: Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity; O-POSSUM: Operative - Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity; P-POSSUM: Portsmouth - Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity; GNRI: Geriatric nutritional risk index; PNI: Prognostic nutritional index; E-PASS: Estimation of physiologic and surgical stress.